Cargando…
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751580/ https://www.ncbi.nlm.nih.gov/pubmed/35028235 http://dx.doi.org/10.7759/cureus.20359 |
_version_ | 1784631706737704960 |
---|---|
author | Gajjela, Harini Kela, Iljena Kakarala, Chandra L Hassan, Mohammad Belavadi, Rishab Gudigopuram, Sri Vallabh Reddy Raguthu, Ciri C Modi, Srimy Sange, Ibrahim |
author_facet | Gajjela, Harini Kela, Iljena Kakarala, Chandra L Hassan, Mohammad Belavadi, Rishab Gudigopuram, Sri Vallabh Reddy Raguthu, Ciri C Modi, Srimy Sange, Ibrahim |
author_sort | Gajjela, Harini |
collection | PubMed |
description | Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology. |
format | Online Article Text |
id | pubmed-8751580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-87515802022-01-12 Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go Gajjela, Harini Kela, Iljena Kakarala, Chandra L Hassan, Mohammad Belavadi, Rishab Gudigopuram, Sri Vallabh Reddy Raguthu, Ciri C Modi, Srimy Sange, Ibrahim Cureus Cardiology Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology. Cureus 2021-12-12 /pmc/articles/PMC8751580/ /pubmed/35028235 http://dx.doi.org/10.7759/cureus.20359 Text en Copyright © 2021, Gajjela et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Gajjela, Harini Kela, Iljena Kakarala, Chandra L Hassan, Mohammad Belavadi, Rishab Gudigopuram, Sri Vallabh Reddy Raguthu, Ciri C Modi, Srimy Sange, Ibrahim Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title | Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title_full | Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title_fullStr | Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title_full_unstemmed | Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title_short | Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go |
title_sort | milestones in heart failure: how far we have come and how far we have left to go |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751580/ https://www.ncbi.nlm.nih.gov/pubmed/35028235 http://dx.doi.org/10.7759/cureus.20359 |
work_keys_str_mv | AT gajjelaharini milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT kelailjena milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT kakaralachandral milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT hassanmohammad milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT belavadirishab milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT gudigopuramsrivallabhreddy milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT raguthuciric milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT modisrimy milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo AT sangeibrahim milestonesinheartfailurehowfarwehavecomeandhowfarwehavelefttogo |